Home / Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIBâD melanoma: a phase 12 trial Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIBâD melanoma: a phase 12 trial unknow ★ 5.0 · 51 reads Sign in to save this Request CodeZLIB.IO18491056 Published2022 Pages1 LanguageUnknown